蛋白质激酶PDK1的编舞及其多样化的基板舞伴
Alejandro E Leroux1, Ricardo M Biondi1
1Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA) - CONICET - Partner Institute of the Max Planck Society, Buenos Aires C1425FQD, Argentina.
The Biochemical journal
|October 4, 2023
概括
蛋白激酶PDK1通过两个关键机制酸化AGC激酶:与Akt/PKB的同位化和基质对接. 它的形状灵活性和PIF-口袋相互作用对于精确的基质向和药物发现至关重要.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- PDK1 (3-酸依赖蛋白质激酶-1) 是一个调节AGC (A-激酶,G-激酶和V-激酶) 蛋白质激酶家族的主激酶.
- PDK1在24种基质上酸化,包括Akt/PKB,S6K,SGK和RSK等关键信号蛋白,这些蛋白对细胞生长,存活和新陈代谢至关重要.
研究的目的:
- 审查调节基质特异性和PDK1.1及时酸化的分子机制.
- 讨论PDK1在全调节中的作用及其在药物发现方面的潜力.
- 批判性地评估PIP3.3对PDK1调节的最新发现.
主要方法:
- 对PDK1功能和调节现有研究的文献综述.
- 分析分子机制,包括局部化和基质对接相互作用.
- 讨论 PDK1.1 的全沟通和构造动态.
主要成果:
- 两个主要机制决定PDK1基质酸化:与Akt/PKB的PIP3依赖同位化和通过PIF口袋的基质对接.
- PDK1与基质疏水基因 (HMs) 的PIF-口袋相互作用对活性至关重要,反映了AGC激酶中的分子内部调节.
- 全长PDK1表现出结构灵活性,影响基质相互作用和酸化效率.
结论:
- PDK1的精确基质向依赖于复杂的分子机制和结构状态.
- 了解PDK1的全调节和基质相互作用为治疗干预提供了显著的潜力.
- 关于PDK1活动的直接PIP3调节的矛盾发现需要进一步调查.
相关概念视频
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Assembly of Signaling Complexes
5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


